Vicarious Surgical reports Q4 net loss $10.5M; NYSE delisting, now on OTCID

Vicarious Surgical Inc.

Q4 GAAP net loss $10.5M ($1.57/sh) vs $13.9M ($2.36/sh) YoY; FY2025 net loss $50.2M ($8.19/sh) vs $63.2M ($10.74/sh) YoY.
Total operating expenses FY2025 $50.0M, down 25% YoY; cash burn $45.1M below initial ~$50M guidance.
FY2026 cash burn guidance approximately $19 million, reflecting continued cost reduction.
NYSE delisted stock March 3, 2026 for market cap <$15M; company did not appeal; now trades on OTCID under RBOT.
Cash and investments $9.8M as of Dec 31, 2025; lower burn extends runway.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Vicarious Surgical Inc. reported the fourth quarter and full year ended December 31, 2025 results: net income GAAP net loss in the fourth quarter of 2025 was $10.5 million, EPS GAAP net loss per share of $1.57.

Period: the fourth quarter and full year ended December 31, 2025
Net income: GAAP net loss in the fourth quarter of 2025 was $10.5 million
EPS: GAAP net loss per share of $1.57
Result: reported results

Exact text from the filing

On March 9, 2026, Vicarious Surgical Inc. (the “Company”) issued a press release announcing its results for the fiscal year and fourth fiscal quarter ended December 31, 2025.

View on SEC.gov

Browse all earnings releases →

Vicarious Surgical Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-025193

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.